LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank60
3Y CAGR+3.3%
5Y CAGR+407.3%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+3.3%/yr
Annual compound
5Y CAGR
+407.3%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
3359.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$20.16M-42.6%
2023$35.14M-20.9%
2022$44.44M+142.8%
2021$18.31M-7.6%
2020$19.82M+330183.3%
2019$6000.00-